Collagen prolyl 3-hydroxylation: a major role for a minor post-translational modification?

References

• Myllyharju J, Kivirikko KI. Collagens, modifying enzymes and their mutations in humans, flies and worms. Trends in Genetics: TIG 2004;20:33–43
   PubMed Web of Science ®Google Scholar
• Eyre DR, Paz MA, Gallop PM. Cross-linking in collagen and elastin. Ann Rev Biochem 1984;53:717–48
   PubMed Web of Science ®Google Scholar
• Berg RA, Prockop DJ. The thermal transition of a non-hydroxylated form of collagen. Evidence for a role for hydroxyproline in stabilizing the triple-helix of collagen. Biochem Biophys Res Commun 1973;52:115–20
   PubMed Web of Science ®Google Scholar
• Kotch FW, Guzei IA, Raines RT. Stabilization of the collagen triple helix by O-methylation of hydroxyproline residues. J Am Chem Soc 2008;130:2952–3
   PubMed Web of Science ®Google Scholar
• Ogle JD, Arlinghaus RB, Logan MA. 3-Hydroxyproline, a new amino acid of collagen. J Biol Chem 1962;237:3667–73
   PubMed Web of Science ®Google Scholar
• Weis MA, Hudson DM, Kim L, Scott M, Wu JJ, Eyre DR. Location of 3-hydroxyproline residues in collagen types I, II, III, and V/XI implies a role in fibril supramolecular assembly. J Biol Chem 2010;285:2580–90
   PubMed Web of Science ®Google Scholar
• Dean DC, Barr JF, Freytag JW, Hudson BG. Isolation of type IV procollagen-like polypeptides from glomerular basement membrane. Characterization of pro-alpha 1(IV). J Biol Chem 1983;258:590–6
   PubMed Web of Science ®Google Scholar
• Risteli J, Bachinger HP, Engel J, Furthmayr H, Timpl R. 7-S collagen: characterization of an unusual basement membrane structure. Eur J Biochem/FEBS 1980;108:239–50
   PubMedGoogle Scholar
• Gryder RM, Lamon M, Adams E. Sequence position of 3-hydroxyproline in basement membrane collagen. Isolation of glycyl-3-hydroxyprolyl-4-hydroxyproline from swine kidney. J Biol Chem 1975;250:2470–4
   PubMed Web of Science ®Google Scholar
• Vranka JA, Sakai LY, Bachinger HP. Prolyl 3-hydroxylase 1, enzyme characterization and identification of a novel family of enzymes. J Biol Chem 2004;279:23615–21
   PubMed Web of Science ®Google Scholar
• Ishikawa Y, Wirz J, Vranka JA, Scott M, Nagata K, Bachinger HP. Biochemical characterization of the prolyl 3-hydroxylase 1ċcartilage-associated proteinċcyclophilin B complex. J Biol Chem 2009;284:17641–7
   PubMed Web of Science ®Google Scholar
• Morello R, Bertin TK, Chen Y, Hicks J, Tonachini L, Monticone M, Castagnola P, Rauch F, Glorieux FH, Vranka J, Bächinger HP, Pace JM, Schwarze U, Byers PH, Weis M, Fernandes RJ, Eyre DR, Yao Z, Boyce BF, Lee B. CRTAP is required for prolyl 3-hydroxylation and mutations cause recessive osteogenesis imperfecta. Cell 2006;127:291–304
   PubMed Web of Science ®Google Scholar
• Barnes AM, Chang W, Morello R, Cabral WA, Weis M, Eyre DR, Leikin S, Makareeva E, Kuznetsova N, Uveges TE, Ashok A, Flor AW, Mulvihill JJ, Wilson PL, Sundaram UT, Lee B, Marini JC. Deficiency of cartilage-associated protein in recessive lethal osteogenesis imperfecta. New England J Med 2006;355:2757–64
   PubMed Web of Science ®Google Scholar
• Cabral WA, Chang W, Barnes AM, Weis M, Scott MA, Leikin S, Makareeva E, Kuznetsova NV, Rosenbaum KN, Tifft CJ, Bulas DI, Kozma C, Smith PA, Eyre DR, Marini JC. Prolyl 3-hydroxylase 1 deficiency causes a recessive metabolic bone disorder resembling lethal/severe osteogenesis imperfecta. Nat Genet 2007;39:359–65
   PubMed Web of Science ®Google Scholar
• Baldridge D, Schwarze U, Morello R, Lennington J, Bertin TK, Pace JM, Pepin MG, Weis M, Eyre DR, Walsh J, Lambert D, Green A, Robinson H, Michelson M, Houge G, Lindman C, Martin J, Ward J, Lemyre E, Mitchell JJ, Krakow D, Rimoin DL, Cohn DH, Byers PH, Lee B. CRTAP and LEPRE1 mutations in recessive osteogenesis imperfecta. Human Mutat 2008;29:1435–42
   PubMed Web of Science ®Google Scholar
• van Dijk FS, Nesbitt IM, Zwikstra EH, Nikkels PGJ, Piersma SR, Fratantoni SA, Jimenez CR, Huizer M, Morsman AC, Cobben JM, van Roij MHH, Elting MW, Verbeke JIML, Wijnaendts LCD, Shaw NJ, Högler W, McKeown C, Sistermans EA, Dalton A, Meijers-Heijboer H, Pals G. PPIB mutations cause severe osteogenesis imperfecta. Am J Human Genet 2009;85:521–7
   PubMed Web of Science ®Google Scholar
• Barnes AM, Carter EM, Cabral WA, Weis M, Chang W, Makareeva E, Leikin S, Rotimi CN, Eyre DR, Raggio CL, Marini JC. Lack of cyclophilin B in osteogenesis imperfecta with normal collagen folding. New England J Med 2010;362:521–8
   PubMed Web of Science ®Google Scholar
• Pyott SM, Schwarze U, Christiansen HE, Pepin MG, Leistritz DF, Dineen R, Harris C, Burton BK, Angle B, Kim K, Sussman MD, Weis M, Eyre DR, Russell DW, McCarthy KJ, Steiner RD, Byers PH. Mutations in PPIB (cyclophilin B) delay type I procollagen chain association and result in perinatal lethal to moderate osteogenesis imperfecta phenotypes. Human Molec Genet 2011;20:1595–609
   PubMed Web of Science ®Google Scholar
• Cundy T. Recent advances in osteogenesis imperfecta. Calcified Tissue Int 2012;90:439–49
   PubMed Web of Science ®Google Scholar
• Christiansen HE, Schwarze U, Pyott SM, AlSwaid A, Al Balwi M, Alrasheed S, Pepin MG, Weis M, Eyre DR, Byers PH. Homozygosity for a missense mutation in SERPINH1, which encodes the collagen chaperone protein HSP47, results in severe recessive osteogenesis imperfecta. Am J Human Genet 2010;86:389–98
   PubMed Web of Science ®Google Scholar
• Becker J, Semler O, Gilissen C, Li Y, Bolz HJ, Giunta C, Bergmann C, Rohrbach M, Koerber F, Zimmermann K, de Vries P, Wirth B, Schoenau E, Wollnik B, Veltman JA, Hoischen A, Netzer C. Exome sequencing identifies truncating mutations in human SERPINF1 in autosomal-recessive osteogenesis imperfecta. Am J Human Genet 2011;88:362–71
   PubMed Web of Science ®Google Scholar
• Alanay Y, Avaygan H, Camacho N, Utine GE, Boduroglu K, Aktas D, Alikasifoglu M, Tuncbilek E, Orhan D, Bakar FT, Zabel B, Superti-Furga A, Bruckner-Tuderman L, Curry CJR, Pyott S, Byers PH, Eyre DR, Baldridge D, Lee B, Merrill AE, Davis EC, Cohn DH, Akarsu N, Krakow D. Mutations in the gene encoding the RER protein FKBP65 cause autosomal-recessive osteogenesis imperfecta. Am J Human Genet 2010;86:551–9
   PubMed Web of Science ®Google Scholar
• Lapunzina P, Aglan M, Temtamy S, Caparros-Martin JA, Valencia M, Leton R, Martínez-Glez V, Elhossini R, Amr K, Vilaboa N, Ruiz-Perez VL. Identification of a frameshift mutation in Osterix in a patient with recessive osteogenesis imperfecta. Am J Human Genet 2010;87:110–14
   PubMed Web of Science ®Google Scholar
• Puig-Hervas MT, Temtamy S, Aglan M, Valencia M, Martinez-Glez V, Ballesta-Martinez MJ, López-González V, Ashour AM, Amr K, Pulido V, Guillén-Navarro E, Lapunzina P, Caparrós-Martín JA, Ruiz-Perez VL. Mutations in PLOD2 cause autosomal-recessive connective tissue disorders within the Bruck syndrome – osteogenesis imperfecta phenotypic spectrum. Human Mutat 2012;33:1444–9
   PubMed Web of Science ®Google Scholar
• Martinez-Glez V, Valencia M, Caparros-Martin JA, Aglan M, Temtamy S, Tenorio J, Pulido V, Lindert U, Rohrbach M, Eyre D, Giunta C, Lapunzina P, Ruiz-Perez VL. Identification of a mutation causing deficient BMP1/mTLD proteolytic activity in autosomal recessive osteogenesis imperfecta. Human Mutat 2012;33:343–50
   PubMed Web of Science ®Google Scholar
• Shaheen R, Alazami AM, Alshammari MJ, Faqeih E, Alhashmi N, Mousa N, Alsinani A, Ansari S, Alzahrani F, Al-Owain M, Alzayed ZS, Alkuraya FS. Study of autosomal recessive osteogenesis imperfecta in Arabia reveals a novel locus defined by TMEM38B mutation. J Med Genet 2012;49:630–5
   PubMed Web of Science ®Google Scholar
• Cho TJ, Lee KE, Lee SK, Song SJ, Kim KJ, Jeon D, Lee G, Kim HN, Lee HR, Eom HH, Lee ZH, Kim OH, Park WY, Park SS, Ikegawa S, Yoo WJ, Choi IH, Kim JW. A single recurrent mutation in the 5′-UTR of IFITM5 causes osteogenesis imperfecta type V. Am J Human Genet 2012;91:343–8
   PubMed Web of Science ®Google Scholar
• Fahiminiya S, Majewski J, Mort J, Moffatt P, Glorieux FH, Rauch F. Mutations in WNT1 are a cause of osteogenesis imperfecta. J Med Genet 2013;50:345--8
   PubMed Web of Science ®Google Scholar
• Schwarze U, Cundy T, Pyott SM, Christiansen HE, Hegde MR, Bank RA, Pals G, Ankala A, Conneely K, Seaver L, Yandow SM, Raney E, Babovic-Vuksanovic D, Stoler J, Ben-Neriah Z, Segel R, Lieberman S, Siderius L, Al-Aqeel A, Hannibal M, Hudgins L, McPherson E, Clemens M, Sussman MD, Steiner RD, Mahan J, Smith R, Anyane-Yeboa K, Wynn J, Chong K, Uster T, Aftimos S, Sutton VR, Davis EC, Kim LS, Weis M, Eyre D, Byers PH. Mutations in FKBP10, which result in Bruck syndrome and recessive forms of osteogenesis imperfecta, inhibit the hydroxylation of telopeptide lysines in bone collagen. Human Molec Genet 2013;22:1–17
   PubMed Web of Science ®Google Scholar
• Lindahl K, Barnes AM, Fratzl-Zelman N, Whyte MP, Hefferan TE, Makareeva E, Brusel M, Yaszemski MJ, Rubin CJ, Kindmark A, Roschger P, Klaushofer K, McAlister WH, Mumm S, Leikin S, Kessler E, Boskey AL, Ljunggren Ö, Marini JC. COL1 C-propeptide cleavage site mutations cause high bone mass osteogenesis imperfecta. Human Mutat 2011;32:598–609
   PubMed Web of Science ®Google Scholar
• Baldridge D, Lennington J, Weis M, Homan EP, Jiang MM, Munivez E, Keene DR, Hogue WR, Pyott S, Byers PH, Krakow D, Cohn DH, Eyre DR, Lee B, Morello R. Generalized connective tissue disease in Crtap-/- mouse. PLoS One 2010;5:e10560 . doi: 10.1371/journal.pone.0010560
   PubMed Web of Science ®Google Scholar
• Pokidysheva E, Tufa S, Bresee C, Brigande JV, Bachinger HP. Prolyl 3-hydroxylase-1 null mice exhibit hearing impairment and abnormal morphology of the middle ear bone joints. Matrix Biol 2013;32:39–44
   PubMed Web of Science ®Google Scholar
• Vranka JA, Pokidysheva E, Hayashi L, Zientek K, Mizuno K, Ishikawa Y, Maddox K, Tufa S, Keene DR, Klein R, Bächinger HP. Prolyl 3-hydroxylase 1 null mice display abnormalities in fibrillar collagen-rich tissues such as tendons, skin, and bones. J Biol Chem 2010;285:17253–62
   PubMed Web of Science ®Google Scholar
• Jarnum S, Kjellman C, Darabi A, Nilsson I, Edvardsen K, Aman P. LEPREL1, a novel ER and Golgi resident member of the Leprecan family. Biochem Biophys Res Commun 2004;317:342–51
   PubMed Web of Science ®Google Scholar
• Mordechai S, Gradstein L, Pasanen A, Ofir R, El Amour K, Levy J, Belfair N, Lifshitz T, Joshua S, Narkis G, Elbedour K, Myllyharju J, Birk OS. High myopia caused by a mutation in LEPREL1, encoding prolyl 3-hydroxylase 2. Am J Human Genet 2011;89:438–45
   PubMed Web of Science ®Google Scholar
• Cavazzini F, Magistroni R, Furci L, Lupo V, Ligabue G, Granito M, Leonelli M, Albertazzi A, Cappelli G. Identification and characterization of a new autoimmune protein in membranous nephropathy by immunoscreening of a renal cDNA library. PLoS One 2012;7:e48845
   PubMed Web of Science ®Google Scholar
• Schuppan D, Glanville RW, Timpl R. Covalent structure of mouse type-IV collagen. Isolation, order and partial amino-acid sequence of cyanogen-bromide and tryptic peptides of pepsin fragment P1 from the alpha 1(IV) chain. Eur J Biochem/FEBS 1982;123:505–12
   PubMedGoogle Scholar
• Fietzek PP, Rexrodt FW, Wendt P, Stark M, Kuhn K. The covalent structure of collagen. Amino-acid sequence of peptide 1-CB6-C2. Eur J Biochem/FEBS 1972;30:163–8
   PubMedGoogle Scholar
• Ishikawa Y, Vranka JA, Boudko SP, Pokidysheva E, Mizuno K, Zientek K, Keene DR, Rashmir-Raven AM, Nagata K, Winand NJ, Bächinger HP. Mutation in cyclophilin B that causes hyperelastosis cutis in American Quarter Horse does not affect peptidylprolyl cis-trans isomerase activity but shows altered cyclophilin B-protein interactions and affects collagen folding. J Biol Chem 2012;287:22253–65
   PubMed Web of Science ®Google Scholar
• Yang C, Park AC, Davis NA, Russell JD, Kim B, Brand DD, Lawrence MJ, Ge Y, Westphall MS, Coon JJ, Greenspan DS. Comprehensive mass spectrometric mapping of the hydroxylated amino acid residues of the alpha1(V) collagen chain. J Biol Chem 2012;287:40598–610
   PubMed Web of Science ®Google Scholar
• Hudson DM, Weis M, Eyre DR. Insights on the evolution of prolyl 3-hydroxylation sites from comparative analysis of chicken and Xenopus fibrillar collagens. PLoS One 2011;6:e19336
   PubMed Web of Science ®Google Scholar
• Eyre DR, Weis M, Hudson DM, Wu JJ, Kim L. A novel 3-hydroxyproline (3Hyp)-rich motif marks the triple-helical C terminus of tendon type I collagen. J Biol Chem 2011;286:7732–6
   PubMed Web of Science ®Google Scholar
• Kimura T, Cheah KS, Chan SD, Lui VC, Mattei MG, van der Rest M, Ono K, Solomon E, Ninomiya Y, Olsen BR. The human alpha 2(XI) collagen (COL11A2) chain. Molecular cloning of cDNA and genomic DNA reveals characteristics of a fibrillar collagen with differences in genomic organization. J Biol Chem 1989;264:13910–16
   PubMed Web of Science ®Google Scholar
• Fernandes RJ, Farnand AW, Traeger GR, Weis MA, Eyre DR. A role for prolyl 3-hydroxylase 2 in post-translational modification of fibril-forming collagens. J Biol Chem 2011;286:30662–9
   PubMed Web of Science ®Google Scholar
• Vranka J, Stadler HS, Bachinger HP. Expression of prolyl 3-hydroxylase genes in embryonic and adult mouse tissues. Cell Struct Funct 2009;34:97–104
   PubMed Web of Science ®Google Scholar
• Tiainen P, Pasanen A, Sormunen R, Myllyharju J. Characterization of recombinant human prolyl 3-hydroxylase isoenzyme 2, an enzyme modifying the basement membrane collagen IV. J Biol Chem 2008;283:19432–9
   PubMed Web of Science ®Google Scholar
• Fujiwara S, Nagai Y. Bovine renal cortex type I collagen: high contents of 3- and 4-hydroxyprolines. J Biochem 1981;89:1397–401
   PubMed Web of Science ®Google Scholar
• Ehrlich H, Deutzmann R, Brunner E, Cappellini E, Koon H, Solazzo C, Yang Y, Ashford D, Thomas-Oates J, Lubeck M, Baessmann C, Langrock T, Hoffmann R, Wörheide G, Reitner J, Simon P, Tsurkan M, Ereskovsky AV, Kurek D, Bazhenov VV, Hunoldt S, Mertig M, Vyalikh DV, Molodtsov SL, Kummer K, Worch H, Smetacek V, Collins MJ. Mineralization of the metre-long biosilica structures of glass sponges is templated on hydroxylated collagen. Nat Chem 2010;2:1084–8
   PubMed Web of Science ®Google Scholar
• Dunn MP, Di Gregorio A. The evolutionarily conserved leprecan gene: its regulation by Brachyury and its role in the developing Ciona notochord. Develop Biol 2009;328:561–74
   PubMed Web of Science ®Google Scholar
• Capellini TD, Dunn MP, Passamaneck YJ, Selleri L, Di Gregorio A. Conservation of notochord gene expression across chordates: insights from the Leprecan gene family. Genesis (New York, NY: 2000) 2008;46:683–96
   PubMed Web of Science ®Google Scholar
• Inouye K, Kobayashi Y, Kyogoku Y, Kishida Y, Sakakibara S, Prockop DJ. Synthesis and physical properties of (hydroxyproline-proline-glycine)10: hydroxyproline in the X-position decreases the melting temperature of the collagen triple helix. Arch Biochem Biophys 1982;219:198–203
   PubMed Web of Science ®Google Scholar
• Inouye K, Sakakibara S, Prockop DJ. Effects of the stereo-configuration of the hydroxyl group in 4-hydroxyproline on the triple-helical structures formed by homogenous peptides resembling collagen. Biochim Biophys Acta 1976;420:133–41
   PubMed Web of Science ®Google Scholar
• Jenkins CL, Bretscher LE, Guzei IA, Raines RT. Effect of 3-hydroxyproline residues on collagen stability. J Am Chem Soc 2003;125:6422–7
   PubMed Web of Science ®Google Scholar
• Mizuno K, Peyton DH, Hayashi T, Engel J, Bachinger HP. Effect of the -Gly-3(S)-hydroxyprolyl-4(R)-hydroxyprolyl- tripeptide unit on the stability of collagen model peptides. FEBS J 2008;275:5830–40
   PubMed Web of Science ®Google Scholar
• Bella J, Eaton M, Brodsky B, Berman HM. Crystal and molecular structure of a collagen-like peptide at 1.9 A resolution. Science 1994;266:75–81
   PubMed Web of Science ®Google Scholar
• Kramer RZ, Venugopal MG, Bella J, Mayville P, Brodsky B, Berman HM. Staggered molecular packing in crystals of a collagen-like peptide with a single charged pair. J Molec Biol 2000;301:1191–205
   PubMed Web of Science ®Google Scholar
• Schumacher MA, Mizuno K, Bachinger HP. The crystal structure of a collagen-like polypeptide with 3(S)-hydroxyproline residues in the Xaa position forms a standard 7/2 collagen triple helix. J Biol Chem 2006;281:27566–74
   PubMed Web of Science ®Google Scholar
• Vitagliano L, Berisio R, Mazzarella L, Zagari A. Structural bases of collagen stabilization induced by proline hydroxylation. Biopolymers 2001;58:459–64
   PubMed Web of Science ®Google Scholar
• Hudson DM, Kim LS, Weis M, Cohn DH, Eyre DR. Peptidyl 3-hydroxyproline binding properties of type I collagen suggest a function in fibril supramolecular assembly. Biochemistry 2012;51:2417–24
   PubMed Web of Science ®Google Scholar
• Woodhead-Galloway J. Structure of the collagen fibril: some variations on a theme of tetragonally packed dimers. Proc Royal Soc B 1980;209:275–97
   Web of Science ®Google Scholar
• Canty EG, Kadler KE. Collagen fibril biosynthesis in tendon: a review and recent insights. Comp Biochem Physiol Part A: Molec Integrat Physiol 2002;133:979–85
   PubMed Web of Science ®Google Scholar
• Hudson BG, Tryggvason K, Sundaramoorthy M, Neilson EG. Alport's syndrome, Goodpasture's syndrome, and type IV collagen. New England J Med 2003;348:2543–56
   PubMed Web of Science ®Google Scholar